查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302477

臉部注射劑市場：按類型、最終用戶分類 - 俄羅斯-烏克蘭衝突、高通貨膨脹的累積影響 - 2023-2030 年全球預測

Facial Injectables Market by Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球臉部注射劑市場預計將在2023年大幅成長至173億美元，年複合成長率為11.69%，預計到2030年將達到驚人的377.2億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球臉部注射劑市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球臉部注射劑市場規模及預測是多少？

2.在預測期內，COVID-19 對全球臉部注射劑市場的抑制要素和影響是什麼？

3.在預測期內，全球臉部注射劑市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球臉部注射劑市場的競爭策略是什麼？

5. 全球臉部注射劑市場的技術趨勢和法律規範是什麼？

6.全球臉部注射劑市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球臉部注射劑市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 人們可支配收入的增加和整容手術的需求增加
      • 世界各地的消費者越來越注重自己的外表。
      • 人們對微創手術越來越感興趣
    • 抑制因素
      • 支持整容手術的有限報銷政策
    • 機會
      • 推出經法規批准的新型填充劑和抗衰老肉毒毒素注射療法
      • 美容旅遊的興起
    • 課題
      • 關於臉部注射產品和相關副作用的嚴重法規問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 注射劑市場：按類型

  • 抗衰老注射
    • A型肉毒桿菌毒素
    • 聚-L-乳酸（PLLA）微粒
  • 真皮填充劑
    • 膠原蛋白填充劑
    • 透明質酸
    • 合成填料

第7章 注射劑市場：按最終用戶分類

  • 美容診所
  • 皮膚科診所
  • 皮膚病學調查
  • 醫院

第8章 北美和南美臉部注射劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太臉部臉部注射劑市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲臉部注射劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-0355054AC48D

The Global Facial Injectables Market is forecasted to grow significantly, with a projected USD 17.30 billion in 2023 at a CAGR of 11.69% and expected to reach a staggering USD 37.72 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Facial Injectables Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Facial Injectables Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers. The Anti-aging Injections commanded largest market share of 52.54% in 2022, followed by Dermal Fillers.

Based on End User, market is studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Hospitals. The Beauty Clinics commanded largest market share of 41.25% in 2022, followed by Dermatology Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.89% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Facial Injectables Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Facial Injectables Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Facial Injectables Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Facial Injectables Market?

4. What is the competitive strategic window for opportunities in the Global Facial Injectables Market?

5. What are the technology trends and regulatory frameworks in the Global Facial Injectables Market?

6. What is the market share of the leading vendors in the Global Facial Injectables Market?

7. What modes and strategic moves are considered suitable for entering the Global Facial Injectables Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Facial Injectables Market, by Type, 2022 vs 2030
  • 4.3. Facial Injectables Market, by End User, 2022 vs 2030
  • 4.4. Facial Injectables Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Disposable Income Among People and Increased Demand for Cosmetic Procedures
      • 5.1.1.2. Increasing Focus on Physical Appearance Among Consumers Globally
      • 5.1.1.3. Rising Inclination Toward Minimally Invasive Procedures Among People
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Reimbursement Policies Supporting Cosmetic Procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of New Fillers and Anti-Aging Botulinum Toxin Injection Therapies coupled with Regulatory Approvals
      • 5.1.3.2. Rise in the Cosmetic Tourism
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Concerns about Facial Injectable Products and Relative Side Effects
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Facial Injectables Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
    • 6.2.1. Botulinum Toxin A
    • 6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
  • 6.3. Dermal Fillers
    • 6.3.1. Collagen Fillers
    • 6.3.2. Hyaluronic Acid
    • 6.3.3. Synthetic Fillers

7. Facial Injectables Market, by End User

  • 7.1. Introduction
  • 7.2. Beauty Clinics
  • 7.3. Dermatology Clinics
  • 7.4. Dermatology Research Institutes
  • 7.5. Hospitals

8. Americas Facial Injectables Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Facial Injectables Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Facial Injectables Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. FACIAL INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. FACIAL INJECTABLES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. FACIAL INJECTABLES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 6. FACIAL INJECTABLES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. FACIAL INJECTABLES MARKET DYNAMICS
  • FIGURE 8. FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. FACIAL INJECTABLES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. FACIAL INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 6. FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 10. FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. FACIAL INJECTABLES MARKET LICENSE & PRICING